stars 1 stars 2 stars 3

CMAC is an internationally leading manufacturing research centre with a unique configuration of academic research, applied, and pre-competitive programmes. Working in partnership with Tier 1, Tier 2, academic, and innovation partners, CMAC's goal is to transform Medicines Development, Manufacture & Supply, and further grow its world-class portfolio of multi-disciplinary collaborative research. This includes the Digital Medicines Manufacturing Research Centre (DM²), Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP), UKRPIF Net Zero Pilot, UKRPIF CMAC Data Lab, and the CMAC Future Manufacturing Research Hub, along with training and translation projects within a world-class facility. The CMAC National Facility provides contract research services to support industries through the delivery of projects within crystallisation (batch & continuous), process development, formulation, product/process analysis and advanced materials characterisation.

CMAC Questions

The CMAC annual revenue was $12.5 million in 2026.

Massimo Bresciani is the Industry Director of CMAC.

67 people are employed at CMAC.

The NAICS codes for CMAC are [611, 61, 6113, 611310, 61131].

The SIC codes for CMAC are [82, 822].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users